A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder

European Neuropsychopharmacology

Volumn 23, Issue 11, 2013, Pages 1348-1363

  Chitty, Kate M ^a   Lagopoulos, Jim ^a   Lee, Rico S C ^a   Hickie, Ian B ^a   Hermens, Daniel F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anterior cingulate cortex; Bipolar disorder; Frontal lobe; Glutamate; Magnetic resonance spectroscopy; Meta analysis; Mismatch negativity

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BIPOLAR DISORDER; FRONTAL CORTEX; HUMAN; META ANALYSIS; MISMATCH NEGATIVITY; NEUROIMAGING; NEUROPHYSIOLOGY; NEUROPSYCHIATRY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SYSTEMATIC REVIEW;

ANTERIOR CINGULATE CORTEX; BIPOLAR DISORDER; FRONTAL LOBE; GLUTAMATE; MAGNETIC RESONANCE SPECTROSCOPY; META-ANALYSIS; MISMATCH NEGATIVITY;

BIPOLAR DISORDER; EVOKED POTENTIALS; FRONTAL LOBE; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 84886775061     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.07.007     Document Type: Review

References (81)

1. Andersson S., Barder H.E., Hellvin T., Lovdahl H., Malt U.F. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder. Bipolar Disord. 2008, 10:888-899.
2. Atkinson R.J., Michie P.T., Schall U. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biol. Psychiatry 2012, 71:98-104.
3. Auer D.P., Putz B., Kraft E., Lipinski B., Schill J., Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry 2000, 47:305-313.
4. Bak L.K., Schousboe A., Waagepetersen H.S. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 2006, 98:641-653.
5. Beneyto M., Meador-Woodruff J.H. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008, 33:2175-2186.
6. Bennett M.R. Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. Prog. Neurobiol. 2011, 95:275-300.
7. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 2000, 47:351-354.
8. Biederman J., Faraone S., Mick E., Wozniak J., Chen L., Ouellette C., Marrs A., Moore P., Garcia J., Mennin D., Lelon E. Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity?. J. Am. Acad. Child Adolesc. Psychiatry 1996, 35:997-1008.
9. Bodatsch M., Ruhrmann S., Wagner M., Müller R., Schultze-Lutter F., Frommann I., Brinkmeyer J., Gaebel W., Maier W., Klosterkötter J., Brockhaus-Dumke A. Prediction of psychosis by mismatch negativity. Biol. Psychiatry 2011, 69:959-966.
10. Bora E., Yucel M., Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J. Affect. Disord. 2009, 113:1-20.
11. Borenstein M., Hedges L., Higgins J.P., Rothstein H. Comprehensive Meta-analysis Version 2 2005, Biostat, Englewood, NJ.
12. Castillo M., Kwock L., Courvoisie H., Hooper S.R. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. Am. J. Neuroradiol. 2000, 21:832-838.
13. Catts S.V., Shelley A.M., Ward P.B., Liebert B., McConaghy N., Andrews S., PT M. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am. J. Psychiatry 1995, 152:213-219.
14. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Earlbaum Associates, Hillsdale, NJ.
15. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 2004, 61:450-458.
16. Davanzo P., Thomas M.A., Yue K., Oshiro T., Belin T., Strober M., McCracken J. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001, 24:359-369.
17. Davanzo P., Yue K., Thomas M.A., Belin T., Mintz J., Venkatraman T.N., Santoro E., Barnett S., McCracken J. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am. J. Psychiatry 2003, 160:1442-1452.
18. DelBello M.P., Cecil K.M., Adler C.M., Daniels J.P., Strakowski S.M. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2006, 31:1264-1273.
19. Dittmann-Balcar A., Juptner M., Jentzen W., Schall U. Dorsolateral prefrontal cortex activation during automatic auditory duration-mismatch processing in humans: a positron emission tomography study. Neurosci. Lett. 2001, 308:119-122.
20. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 1997, 315:629-634.
21. 1H-MRS study. Bipolar Disord. 2007, 9(Suppl. 1):119-127.
22. Friedman S.D., Dager S.R., Parow A., Hirashima F., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol. Psychiatry 2004, 56:340-348.
23. Frye M.A., Watzl J., Banakar S., O'Neill J., Mintz J., Davanzo P., Fischer J., Chirichigno J.W., Ventura J., Elman S., Tsuang J., Walot I., Thomas M.A. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007, 32:2490-2499.
24. Giard M.H., Perrin F., Pernier J., Bouchet P. Brain generators implicated in the processing of auditory stimulus deviance: a topographic event-related potential study. Psychophysiology 1990, 27:627-640.
25. Giard M.H., Lavikahen J., Reinikainen K., Perrin F., Bertrand O., Pernier J., Näätänen R. Separate representation of stimulus frequency, intensity, and duration in auditory sensory memory: an event-related potential and dipole-model analysis. J. Cognitive Neurosci. 1995, 7:133-143.
26. Gigante A.D., Bond D.J., Lafer B., Lam R.W., Young L.T., Yatham L.N. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 2012, 14:478-487.
27. Haldane M., Frangou S. New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:943-960.
28. Hall M.-H., Rijsdijk F., Kalidindi S., Schulze K., Kravariti E., Kane F., Sham P., Bramon E., Murray R.M. Genetic overlap between bipolar illness and event-related potentials. Psychol. Med. 2007, 37:667-678.
29. Hall M.H., Schulze K., Rijsdijk F., Kalidindi S., McDonald C., Bramon E., Murray R.M., Sham P. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley bipolar twin and family study. Psychol. Med. 2009, 39:1277-1287.
30. Hashimoto K., Sawa A., Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry 2007, 62:1310-1316.
31. Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:438-458.
32. Hedges L., Olkin I. Statistical Methods for Meta-Analysis 1985, Academic Press, Orlando.
33. Heekeren K., Daumann J., Neukirch A., Stock C., Kawohl W., Norra C., Waberski T.D., Gouzoulis-Mayfrank E. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology 2008, 199:77-88.
34. Hermens D.F., Ward P.B., Hodge M.A.R., Kaur M., Naismith S.L., Hickie I.B. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:822-829.
35. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
36. Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327:557-560.
37. Jahshan C., Wynn J., Mathis K., Altshuler L., Glahn D., Green M. Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. Bipolar Disord. 2012, 14:239-248.
38. Javitt D.C., Schroeder C.E., Steinschneider M., Arezzo J.C., Ritter W., Vaughan H.G. Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia. Electroencephalogr. Clin. Neurophysiol. Suppl. 1995, 44:161-175.
39. Javitt D.C., Steinschneider M., Schroeder C.E., Arezzo J.C. Role of cortical N-methyl-d-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Nat. Acad. Sci 1996, 93:11962-11967.
40. Jemel B., Achenbach C., Muller B.W., Ropcke B., Oades R.D. Mismatch negativity results from bilateral asymmetric dipole sources in the frontal and temporal lobes. Brain Topogr. 2002, 15:13-27.
41. Kasai K., Yamada H., Kamio S., Nakagome K., Iwanami A., Fukuda M., Yumoto M., Itoh K., Koshida I., Abe O., Kato N. Do high or low doses of anxiolytics and hypnotics affect mismatch negativity in schizophrenic subjects? An EEG and MEG study. Clin. Neurophysiol. 2002, 113:141-150.
42. Kaur M., Battisti R.A., Ward P.B., Ahmed A., Hickie I.B., Hermens D.F. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups. Schizophr. Res. 2011, 130:203-209.
43. Kaur M., Battisti R.A., Lagopoulos J., Ward P.B., Hickie I.B., Hermens D.F. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster. J. Psychiatry Neurosci. 2012, 37.
44. Kiang M., Braff D.L., Sprock J., Light G.A. The relationship between preattentive sensory processing deficits and age in schizophrenia patients. Clin. Neurophysiol. 2009, 120:1949-1957.
45. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., Epperson C.N., Goddard A., Mason G.F. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 2002, 7(Suppl. 1):S71-80.
46. Kugaya A., Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr. 2005, 10:808-819.
47. Malhi G.S., Ivanovski B., Hadzi-Pavlovic D., Mitchell P.B., Vieta E., Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord. 2007, 9:114-125.
48. Michael N., Erfurth A., Ohrmann P., Arolt V., Heindel W., Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol. Med. 2003, 33:1277-1284.
49. Michael N., Erfurth A., Ohrmann P., Gossling M., Arolt V., Heindel W., Pfleiderer B. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 2003, 168:344-346.
50. Michie P.T. What has MMN revealed about the auditory system in schizophrenia?. Int. J. Psychophysiol. 2001, 42:177-194.
51. Moore C.M., Biederman J., Wozniak J., Mick E., Aleardi M., Wardrop M., Dougherty M., Harpold T., Hammerness P., Randall E., Renshaw P.F. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am. J. Psychiatry 2006, 163:316-318.
52. Moore C.M., Frazier J.A., Glod C.A., Breeze J.L., Dieterich M., Finn C.T., Frederick B.d., Renshaw P.F. Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J. Am. Acad. Child Adolesc. Psychiatry 2007, 46:524-534.
53. Murakami T., Nakagome K., Kamio S., Kasai K., Iwanami A., Hiramatsu K.-I., Fukuda M., Hata A., Honda M., Watanabe A., Kato N. The effects of benzodiazepines on event-related potential indices of automatic and controlled processing in schizophrenia: a preliminary report. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:651-661.
54. Nery F.G., Stanley J.A., Chen H.-H., Hatch J.P., Nicoletti M.A., Monkul E.S., Lafer B., Soares J.C. Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study. J. Psychiatry Res. 2010, 44:278-285.
55. Nieuwenhuys R. The neocortex. An overview of its evolutionary development, structural organization and synaptology. Anat. Embryol. 1994, 4:307-337.
56. Nowak G., Ordway G.A., Paul I.A. Alterations in the N-methyl-d-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 1995, 675:157-164.
57. Oknina L.B., Wild-Wall N., Oades R.D., Juran S.A., Ropcke B., Pfueller U., Weisbrod M., Chan E., Chen E.Y.H. Frontal and temporal sources of mismatch negativity in healthy controls, patients at onset of schizophrenia in adolescence and others at 15 years after onset. Schizophr. Res. 2005, 76:25-41.
58. Olley A., Malhi G.S., Mitchell P.B., Batchelor J., Lagopoulos J., Austin M.-P.V. When euthymia is just not good enough: the neuropsychology of bipolar disorder. J. Nerv. Ment. Dis. 2005, 193:323-330.
59. Olvera R.L., Caetano S.C., Fonseca M., Nicoletti M., Stanley J.A., Chen H.H., Hatch J.P., Hunter K., Pliszka S.R., Soares J.C. Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J. Child Adolesc. Psychopharmacol. 2007, 17:461-473.
60. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Nat. Acad. Sci 1998, 95:13290-13295.
61. Ongur D., Jensen J.E., Prescot A.P., Stork C., Lundy M., Cohen B.M., Renshaw P.F. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol. Psychiatry 2008, 64:718-726.
62. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry 2001, 49:741-752.
63. Rao J.S., Harry G.J., Rapoport S.I., Kim H.W. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 2010, 15:384-392.
64. Rao J.S., Kellom M., Reese E.A., Rapoport S.I., Kim H.W. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J. Affect. Disord. 2012, 136:63-71.
65. Salisbury D.F., Kuroki N., Kasai K., Shenton M.E., McCarley R.W. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch. Gen. Psychiatry 2007, 64:521-529.
66. Sanacora G., Zarate C.A., Krystal J.H., Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug. Discov. 2008, 7:426-437.
67. Schall U., Johnston P., Todd J., Ward P.B., Michie P.T. Functional neuroanatomy of auditory mismatch processing: an event-related fMRI study of duration-deviant oddballs. NeuroImage 2003, 20:729-736.
68. Senaratne R., Milne A.M., MacQueen G.M., Hall G.B.C. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res. 2009, 172:205-209.
69. Singh M., Spielman D., Adleman N., Alegria D., Howe M., Reiss A., Chang K. Brain glutamatergic characteristics of pediatric offspring of parents with bipolar disorder. Psychiatry Res. 2010, 182:165-171.
70. Strawn J.R., Patel N.C., Chu W.J., Lee J.H., Adler C.M., Kim M.J., Bryan H.S., Alfieri D.C., Welge J.A., Blom T.J., Nandagopal J.J., Strakowski S.M., Delbello M.P. Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51:642-651.
71. Sun Q., Zheng Z., Zou K., Sun X. Matching analysis of event related potentials in patients with bipolar disorder. Sheng wu yi xue gong cheng xue za zhi. J. Biomed. Eng. Shengwu yixue gongchengxue zazhi 2011, 28:563-566.
72. Toyomaki A., Kusumi I., Matsuyama T., Kako Y., Ito K., Koyama T. Tone duration mismatch negativity deficits predict impairment of executive function in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:95-99.
73. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., Javitt D.C. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 2000, 57:1139-1147.
74. Umbricht D., Koller R., Schmid L., Skrabo A., Grubel C., Huber T., Stassen H. How specific are deficits in mismatch negativity generation to schizophrenia?. Biol. Psychiatry 2003, 53:1120-1131.
75. Umbricht D., Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr. Res. 2005, 76:1-23.
76. Verkhratsky A., Kirchhoff F. NMDA Receptors in Glia. Neuroscientist 2007, 13:28-37.
77. Wienberg M., Glenthoj B.Y., Jensen K.S., Oranje B. A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers. J. Psychopharmacol. 2010, 24:1183-1192.
78. Woo T.-U.W., Walsh J.P., Benes F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 2004, 61:649-657.
79. Yildiz-Yesiloglu A., Ankerst D.P. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:969-995.
80. Yuksel C., Ongur D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol. Psychiatry 2010, 68:785-794.
81. Zuo Z., Fang H. Glutamate transporter type 3 attenuates the activation of N-methyl-d-aspartate receptors co-expressed in Xenopus oocytes. J. Exp. Biol 2005, 208:2063-2070.